Navigation Links
Blood-incompatible infant heart transplants safe, may save more lives

ORLANDO, Nov. 5 ABO-incompatible heart transplantation (heart transplantation among non-compatible blood groups) can be safely performed in infants a year old or younger, researchers reported at the American Heart Associations Scientific Sessions 2007.

The analysis, based on national data reported to the United Network for Organ Sharing (UNOS), found that transplanting infant hearts across incompatible blood group is as safe as transplantation with compatible blood group types.

There was no difference in outcome between incompatible and compatible transplantation in these infants, said Luca A. Vricella, M.D., senior author of the study. Survival between the two groups was similar at three years. Nishant Patel, B.A., third-year medical student, presented the study findings at the associations annual conference.

ABO-incompatible heart transplantation can be performed safely in infants with a low incidence of hyperacute rejection, Patel said. ABO-incompatible heart transplantation should be considered in infants to maximize donor organ utilization and reduce mortality among infants.

Vricella said the impact of using incompatible donor hearts could significantly reduce the number of infants who die while on the waiting list to receive donor hearts.

Mortality could be reduced by at least 20 percent by using incompatible donors, said Vricella, chief of pediatric heart transplantation at Johns Hopkins Medical Institutions in Baltimore, Md. There would be a huge impact on infants who otherwise have to rely on a very small donor pool.

Up to 40 percent of infants die while waiting for a donor heart. The average wait on the list exceeds two months.

The whole concept of transplanting infants across blood barriers comes from the necessity to reduce waiting time on the list, Vricella said.

The study examined data on infant heart transplant recipients reported to UNOS from 1999 to 2007. Of the 591 infants who underwent transplantation, 35 infants (6 percent) received hearts from ABO-incompatible donors. Two ABO-compatible infants died from hyperacute rejection, while no ABO- incompatible infants died from hyperacute rejection.

ABO-incompatibility did not predict mortality. The statistical analysis was adjusted for the different size cohorts, assuring statistical significance.

Survival in both groups reached 75 percent at three years after transplantation. Infants with congenital heart disease (defects existing since birth) represent the predominant group requiring transplantation.

In the study, 71 percent of the incompatible recipients had some form of structural heart disease compared to 66 percent in the compatible group.

Cardiomyopathies, disorders of the heart muscle, represent a second condition requiring transplantation in infants.

Heart function deteriorates until the only option is transplantation. In the study, 11 percent of the incompatible recipients had cardiomyopathy versus 29 percent in the compatible group.

One key reason incompatible transplantation works in infants is the role of antibodies known as isohemagglutinins.

Until age 12 to 14 months, infants have immature immune systems with little or no production of these antibodies. That means they will not have pre-formed antibodies against the donor heart, lowering the risk of rejection.

Vricella said the most challenging transplants are in infants born with structural heart disease, congenital heart anomalies. These infants are being transplanted as a re-operation, which involves conversion of their anatomy to normal so that they can accommodate the donor heart, he said.

Vricella said that successful infant heart transplantation means an infant can go home and have a great quality of life.


Contact: Karen Astle
American Heart Association

Related medicine news :

1. Nicotine in breast milk disrupts infants sleep patterns
2. Shaking may cause brain damage and serious long-term effects to infants
3. Maternal depression and controlling behavior associated with increased stress response in infants
4. Repeat steroids to premature infants linked to cerebral palsy
5. Babies raised in bilingual homes learn new words differently than infants learning one language
6. Joint Center Says New Approach Required to Reduce Black Infant Mortality
7. After Infant Gripe Water Recall Scare, Homeopathic Medicine Offers Safe Alternative
8. Vaginal progesterone gel may improve infant outcomes and...
9. Research shows how genetic mutation causes epilepsy in infants
10. Combination vaccines okay for infants, study shows
11. New York Citys infant mortality rate declined in 2006
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... European Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, ... (UNON) for the opening of the 5th African Network for Drugs and Diagnostics ...
(Date:11/25/2015)... Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... da Vinci surgical robot is being more and more widely heralded as a breakthrough ... assisted da Vinci method has over traditional laparoscopic surgery is that it can greatly ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug ... a new cutting edge recovery program that has been 50 years in the making. ... individuals with the purpose to free addicts from the symptoms and negative behaviors of ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy ... personal heating products business. Cozy Products explains what this means for business moving ... well with the Cozy Products business model: to sell personal heaters that reduce energy ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
(Date:11/25/2015)... Asia -based venture ... and the New Investors will make a direct equity ... private placement. The financing will help IOPtima to continue ... in the treatment of glaucoma, as well as to ... system with the U.S. Food and Drug Administration, commencing ...
(Date:11/25/2015)... , November 25, 2015 Developmental, commercial, ... in boosting the profitability of pharmaceutical products, says ... and regulatory/legal strategies all play a key ... says GBI Research . --> ... a key role in boosting the profitability of pharmaceutical products, ...
Breaking Medicine Technology: